Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Rathmell: To improve funding outlook, we must reverse distrust in science
NCI Director's Report

Rathmell: To improve funding outlook, we must reverse distrust in science

With NCI funding expected to remain flat through fiscal year 2025, health professionals and leaders in oncology should use this time to amp up institutional efforts to collaborate and rebuild trust in science, NCI Director Kimryn Rathmell said.
April 12, 2024
Vol.50 No.15
By Matthew Bin Han Ong
In Brief

Pfizer’s Albert Bourla to receive the AACR Outstanding Achievement Award for Service to Cancer Science and Medicine

Albert Bourla, Pfizer’s chairman and CEO, will receive the 2024 the American Association for Cancer Research Outstanding Achievement Award for Service to Cancer Science and Medicine during the AACR Annual Meeting 2024, to be held April 5-10 in San Diego, California. 
April 05, 2024
Vol.50 No.14
In Brief

AACR recognizes 2023-2024 research grantees

The American Association for Cancer Research has named its newest class of grant recipients.
April 05, 2024
Vol.50 No.14
In Brief

Lillian Siu named 2024-2025 president-elect of AACR

Lillian L. Siu was named the AACR president-elect for 2024-2025. 
March 15, 2024
Vol.50 No.11
In Brief

Hidalgo, Paskett, Politi, Soria, Wu named to AACR board

The following five individuals have been elected to the AACR Board of Directors for the 2024-2027 term.
March 15, 2024
Vol.50 No.11
In Brief

AACR publishes annual impact report

The American Association for Cancer Research presented its 2023 Annual Impact Report. 
March 08, 2024
Vol.50 No.10
In Brief

AACR announces 2024 scientific achievement awards

The American Association for Cancer Research will honor the following cancer researchers and physician-scientists during the 2024 AACR annual meeting at the San Diego Convention Center April 5-10.
March 01, 2024
Vol.50 No.09
In Brief

Chi Van Dang to receive 2024 AACR-Margaret Foti Award

Chi Van Dang will receive the 2024 AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research. The recognition will take place during this year’s AACR annual meeting, April 5-10 in San Diego, CA.
February 23, 2024
Vol.50 No.08
SABCS: 46 years at the forefront of clinical and translational research in breast cancer—and still growing
Guest Editorial

SABCS: 46 years at the forefront of clinical and translational research in breast cancer—and still growing

The 2023 San Antonio Breast Cancer Symposium (SABCS), held Dec. 5-9 at the city’s Henry B. Gonzalez Convention Center, had a record-setting attendance with 10,874 registered attendees from 102 countries.
February 16, 2024
Vol.50 No.07
By Virginia Kaklamani, Srivani Ravoori and Carlos L. Arteaga
In Brief

Steven Rosenberg to receive 2024 AACR Award for Lifetime Achievement in Cancer Research

Steven A. Rosenberg, fellow of the AACR Academy, was named the recipient of the 2024 AACR Award for Lifetime Achievement in Cancer Research. 
February 16, 2024
Vol.50 No.07

Posts navigation

Previous1234…10Next

Trending Stories

  • The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
    In a time of uncertainty, “react to the knowns, not the fear”
  • The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
  • How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest
  • In the Headlines: What if curing diseases was treated like a business?
  • Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures
  • “Forward funding” NIH budget plan would make competing for grants much harder

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2025 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation
Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account